Clearstead Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Clearstead Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-304	Closed	-$66K	–	1337
2021 Q1	$66K	Hold	304	–	–	0.01%	505
2020 Q4	$35K	Hold	304	–	–	﹤0.01%	561
2020 Q3	$30K	Hold	304	–	–	﹤0.01%	542
2020 Q2	$37K	Hold	304	–	–	﹤0.01%	465
2020 Q1	$27K	Buy	+304	New	+$32.2K	﹤0.01%	479

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Clearstead Advisors's GWPH Position: Q2 2021 in Review

Clearstead Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 304 shares — an estimated $66K sold.

Clearstead Advisors first reported a position in GWPH in Q1 2020 and held it in 5 quarters. The position peaked at $66K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Clearstead Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Clearstead Advisors sold 304 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $66K.
Clearstead Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 5 quarters.
Clearstead Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $66K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Clearstead Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.